Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,720.00
(
-0.32%
)
Dow Jones
46,022.20
(
-0.44%
)
Brent Oil
104.31
(
-2.13%
)
Bitcoin
70,209.18
(
-1.45%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jb_118 post# 107919

Tuesday, 11/02/2010 7:40:04 PM

Tuesday, November 02, 2010 7:40:04 PM

Post# of 257259

how would MNTA know whether TEVA infringed their patents in characterizing lovenox?

Well, MNTA essentially drafted the FDA requirements for approvability set forth in #msg-52582225 to coincide with MNTA’s patent estate on Lovenox characterization. So it would be a good bet that any approved product would be infringing MNTA’s patents.

To reiterate, I don’t think this angle will ever actually come into play.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now